CompletedPhase 4

Dextenza for Post-operative Treatment of Pterygium

United States20 participantsStarted 2020-07-15

Plain-language summary

DEXTENZA for the Treatment of Post-Surgical Pain and Inflammation Compared to Standard of Care Topical Cortico-steroid Treatment in Patients who Undergo Bilateral Pterygium Surgery

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: patients with bilateral pterygium - Exclusion Criteria: none \-

What they're measuring

Patient pain level follow pterygium removal

Timeframe: 2 months

inflammation

Timeframe: 2 months

Trial details

NCT IDNCT04351737

SponsorBrandon Eye Associates, PA

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-15

View on ClinicalTrials.gov More Pterygium of Both Eyes trials